Expansion into Bio- and Genome-Related Equipment and the Magnet Business
First written in FY2016. 4 of 10 entries say "Restated". Latest entry: 2026-09-01.
No other company in this theme has enough history to compare yet.
- 2026-09-01RestatedGovernance
「▼ Group synergies — RORZE IAS and Nanoverse Technologies」
The company presented synergies among group companies, including RORZE IAS and Nanoverse, as a foundation for growth. - FY2026AdvancedAnnual report
「ローツェライフサイエンス株式会社 acquired all shares of ジェノスタッフ株式会社, based in Bunkyo-ku, Tokyo, making it a wholly owned subsidiary.」
In the Life Science business, the Company made ジェノスタッフ株式会社, which conducts tissue staining and gene function analysis, a wholly owned subsidiary. - FY2023RestatedAnnual report
「In the Life Science business, shipment delays and other effects of COVID-19 are expected to be resolved. The Company will coordinate with its affiliates and pursue sales promotion activities targeting China.」
Although the magnet business is not mentioned, the Company has indicated its intention to continue the Life Science business through coordination with affiliates and sales in China. - FY2021SoftenedAnnual report
「JIKA JIKA CO.,LTD., which had been a consolidated subsidiary through the previous consolidated fiscal year, was excluded from the scope of consolidation because its liquidation was completed in October 2020.」
The liquidation of JIKA JIKA, the company operating the magnet business, which had been one of the new business areas, was completed, further narrowing the scope of the magnet business. The Life Science business, meanwhile, continues. - FY2020SoftenedAnnual report
「JIKA JIKA CO.,LTD. (liquidation proceedings commenced in December 2019)」
For the magnet business, which had been positioned as one of the new business areas, the commencement of liquidation proceedings for JIKA JIKA was disclosed, indicating a reduction in the scope of its expansion. - FY2019AdvancedAnnual report
「The Company also established a joint venture in China and focused on developing the Chinese market.」
In the Life Science field, the Company established a joint venture in China and moved into the phase of developing the Chinese market. - FY2018RestatedAnnual report
「The Group has two reportable segments: the Semiconductor and LCD-Related Equipment Business, which develops, manufactures and sells dust-free transfer equipment for the semiconductor and LCD industries, and the Life Science Business, which develops, manufactures and sells bio- and genome-related equipment.」
Bio- and genome-related equipment continues to be positioned as a core business area within the Life Science business. - FY2018-Q2RestatedAnnual report
「On 1 March 2017, the Company made its affiliate アイエス・テクノロジー・ジャパン株式会社 a wholly owned subsidiary and changed its corporate name to ローツェライフサイエンス株式会社, positioning it as the core of the Life Science business from the first-quarter consolidated accounting period.」
The positioning of ローツェライフサイエンス株式会社 as the core of the Life Science business after becoming a wholly owned subsidiary and changing its corporate name continued to be stated this quarter. - FY2018-Q1AdvancedAnnual report
「From the cumulative period of the first quarter, the Company made its affiliate アイエス・テクノロジー・ジャパン株式会社 a wholly owned subsidiary and changed its corporate name to ローツェライフサイエンス株式会社, positioning it as the core company of the Life Science business.」
The Company made its affiliate a wholly owned subsidiary and changed its corporate name, positioning it as the core company of the Life Science business. - FY2016First statedAnnual report
「In addition to its existing business areas, the Company is expanding into new business areas, including bio- and genome-related equipment and the magnet business.」
The Company has positioned bio and genome-related equipment and magnets as new business areas outside the semiconductor and LCD transfer equipment fields.